FDA Guidance titled “Further Testing of Donations that are Reactive on a Licensed Donor Screening Test for Antibodies to Hepatitis C Virus; Guidance for Industry” was released on October 2, 2019 and recommends that CTS modify our current HCV reflex testing algorithm to support these best practices. The new algorithm will take effect on April 20, 2020.
Check out the Communication page for the complete details by clicking the link: Communications
As communicated on January 21, 2020, CTS will implement the licensed Grifols Babesia test for sample...
On February 18, 2019, the new CTS Laboratory Information System was successfully implemented in Tamp...
As an organization dedicated to the safety of the world’s blood and plasma supply, Creative Testing...
CTS Tampa has implemented the Ortho Vitros Anti-SARS-CoV-2 Total test which qualitatively detects an...
Just a reminder that the revised client forms implement today! Don't forget to toss your o...
As previously mentioned in Zika communications distributed on September 21 and October 12, 2018; ord...